- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- 【Updated on June 30, 2025】Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
A20 Versatile ultrasound contrast agent for diagnosis and therapy
-
- Kawabata Ken-ichi
- Life Science Research Center, Central Research Laboratory, Hitachi, Ltd.
-
- Yoshizawa Akiko
- Life Science Research Center, Central Research Laboratory, Hitachi, Ltd.
-
- Sugita Nami
- Life Science Research Center, Central Research Laboratory, Hitachi, Ltd.
-
- Hirata Koji
- Life Science Research Center, Central Research Laboratory, Hitachi, Ltd.
-
- Habara Hideta
- Life Science Research Center, Central Research Laboratory, Hitachi, Ltd.
-
- Shirai Toru
- Life Science Research Center, Central Research Laboratory, Hitachi, Ltd.
-
- Yoshikawa Hideki
- Life Science Research Center, Central Research Laboratory, Hitachi, Ltd.
-
- Azuma Takashi
- Life Science Research Center, Central Research Laboratory, Hitachi, Ltd.
-
- 佐々木 一昭
- 日立・中研
-
- Umemura Shin-ichiro
- Life Science Research Center, Central Research Laboratory, Hitachi, Ltd.
Bibliographic Information
- Other Title
-
- A20 診断・治療両用超音波造影剤に関する研究
Description
We propose the use of nano-sized emulsion systems which change their phase from liquid to gas, generating microbubbles, upon exposure of ultrasound pulses for site-specific ultrasound contrast agent. They also have potentials to be used for sensitizers in ultrasonic therapies. In in vitro experiments, it was confirmed that our nano-sized emulsion system changes its phase by ultrasound exposure at relatively low acoustic intensity (less than 10W/cm2). Further, in vivo experiments using subcutaneously implanted murine tumor showed that the phase can be shifted by ultrasound exposure under the same conditions as above in vitro experiments. It was also found that focused ultrasound at an acoustic intensity of 40W/cm2 contiguously exposed after the phase shift is established in the tumor tissues induce therapeutic effects at the focus. Our results indicated the potential usefulness of the nano-sized emulsion system as a versatile agent for ultrasonic diagnosis and therapy. Part of this work was supported by the Japanese Ministry of Education, Culture, Sports, Science and Technology through a grant-in-aid for the creation of innovations through business-academic public sector cooperation.
Journal
-
- Proceedings of the Annual Meeting of the Japan Society of Sonochemistry
-
Proceedings of the Annual Meeting of the Japan Society of Sonochemistry 14 (0), 64-66, 2005
Japan Society of Sonochemistry
- Tweet
Details 詳細情報について
-
- CRID
- 1390282681029413376
-
- NII Article ID
- 110009710309
-
- ISSN
- 24241512
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- CiNii Articles
-
- Abstract License Flag
- Disallowed